These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1621224)

  • 1. Xenografts: is there a future?
    Barker CF; Markmann JF
    Surgery; 1992 Jul; 112(1):3-5. PubMed ID: 1621224
    [No Abstract]   [Full Text] [Related]  

  • 2. [Xenotransplantation: current status and future prospects].
    Bach FH; Słomińska EM; Smoleński RT
    Kardiol Pol; 2003 Dec; 59 Suppl 2():II17-25. PubMed ID: 20527124
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular events associated with peripherally induced rejection of mature neural xenografts placed into neonatal rat brains.
    Backes MG; Lund RD; Lagenaur CF; Kunz HW; Gill TJ
    J Comp Neurol; 1990 May; 295(3):428-37. PubMed ID: 2351761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenotransplantation: a challenge for the future of transplant medicine.
    Remuzzi G
    Schweiz Med Wochenschr; 1998 Jun; 128(24):952-60. PubMed ID: 9674059
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of the target antigens of hyperacute xenogeneic rejection in discordant combinations.
    Calmus Y; Ayani E; Chereau C; Kahan A; Houssin D; Weill B
    Transplant Proc; 1993 Feb; 25(1 Pt 1):379-81. PubMed ID: 8438343
    [No Abstract]   [Full Text] [Related]  

  • 6. Xenotransplantation literature update October-December, 2003.
    Buhler LH
    Xenotransplantation; 2004 Mar; 11(2):216-8. PubMed ID: 14962284
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells.
    Tanaka K; Sonoda K; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2878-84. PubMed ID: 11687532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Xenotransplantation is the hope of the future. Genetic modification of the donor, the pig, is better than fighting organ rejection by submitting patients to immunosuppression with frequent side effect].
    Groth CG
    Lakartidningen; 2002 Jan; 99(4):252-4. PubMed ID: 11871187
    [No Abstract]   [Full Text] [Related]  

  • 9. Importance of cell-mediated immune responses in rejection of concordant heart xenografts in primates.
    Shah AS; Itescu S; O'Hair DP; Tugulea S; Kwiatkowski PA; Liu Z; Platt JL; Rose EA; Suciu-Foca N; Michler RE
    Transplant Proc; 1996 Apr; 28(2):775-6. PubMed ID: 8623396
    [No Abstract]   [Full Text] [Related]  

  • 10. Xenografts of organ-cultured fetal pig pancreas in NOD mice: a comparison with allografts and isografts in transiently immunosuppressed recipients.
    Mandel TE; Koulmanda M; Loudovaris T
    Transplant Proc; 1990 Apr; 22(2):816-8. PubMed ID: 2327030
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental progress and clinical perspectives in xenotransplantation.
    Cooper DK
    Transplant Proc; 1996 Jun; 28(3):1153. PubMed ID: 8658606
    [No Abstract]   [Full Text] [Related]  

  • 12. Microglia, MHC expression and graft rejection.
    Lund RD; Banerjee R; Rao K
    Neuropathol Appl Neurobiol; 1994 Apr; 20(2):202-3. PubMed ID: 8072663
    [No Abstract]   [Full Text] [Related]  

  • 13. Xenotransplantation literature update January-February, 2004.
    Buhler LH
    Xenotransplantation; 2004 May; 11(3):301-3. PubMed ID: 15099212
    [No Abstract]   [Full Text] [Related]  

  • 14. New directions for organ transplantation.
    Platt JL
    Nature; 1998 Apr; 392(6679 Suppl):11-7. PubMed ID: 9579856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of MHC deficient mouse heterotopic cardiac allografts and xenografts.
    Campos L; Deli BC; Kern JH; Kim JI; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1995 Feb; 27(1):254-5. PubMed ID: 7878991
    [No Abstract]   [Full Text] [Related]  

  • 16. Xenotransplantation-current status and future perspectives.
    Cozzi E; Bosio E; Seveso M; Vadori M; Ancona E
    Br Med Bull; 2005; 75-76():99-114. PubMed ID: 16723634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenotransplantation: progress toward clinical development.
    Ferran C; Badrichani AZ; Cooper JT; Stroka DM; Bach FH
    Adv Nephrol Necker Hosp; 1997; 27():391-420. PubMed ID: 9408458
    [No Abstract]   [Full Text] [Related]  

  • 18. Rejection mechanisms in transplantation.
    Game DS; Warrens AN; Lechler RI
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):832-8. PubMed ID: 11732119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interview with Jean-Paul Soulillou. What is the future of xenograft?].
    Soulillou JP
    Ann Med Interne (Paris); 1996; 147(3):161-4. PubMed ID: 8796092
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperacute rejection of xenografts in the complete absence of antibody.
    Johnston PS; Lim SM; Wang MW; Wright L; White DJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):877-9. PubMed ID: 1990711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.